Technical420 Site Search

Unlike Tilray Inc. (TLRY), which received multiple downgrades after reporting earnings, Cronos Group Inc. (CRON.TO) (CRON) has received several price targets hikes after published fourth quarter revenues that exceeded Wall Street’s expectations. The broker-dealers that raised price targets on Cronos are Cowen and Company, Stifel, Cormark Securities, and PI Financial.…

Earlier this week, Aphria Inc. (APHA.TO) (APHA) and Tilray (TLRY) launched a new website that combined the companies which comes ahead of a planned mega-merger. The development captured the attention of mainstream financial media firms and the combined company has been getting great coverage. Last week, we listened to a…

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), today announces its 2020 fourth quarter and full-year business results. “Our fourth quarter 2020 results are the summation of the hard work and perseverance the Company has put into this past year despite the challenges of 2020. As we…

Last year, we highlighted MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) as one of the most misunderstood and undervalued cannabis companies. Following a series of transformational announcements, we remain bullish on the business and believe that our readers need to be aware of how the story has advanced…

2021 has been a wild year for the cannabis sector and has been highlighted by extreme moves to the upside and the downside. Although we are not even through the first quarter of the calendar year, the cannabis sector has been the subject of conversation with key members of the…

Last month, we highlighted Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) as a leading plant-based extraction company that is focused on cannabis, hemp, and functional mushroom sector. We have always referred to Pure Extracts as a legitimate and differentiated play on the cannabis, functional mushroom and burgeoning…

When compared to other mergers and acquisitions (M&A) in the cannabis industry, the Aphria Inc. (APHA.TO) (APHA) and Tilray, Inc. (TLRY) merger is one of the most significant transactions to be reported by the cannabis sector in recent years. We considered the combined company to be a leading play on…

Although Tilray Inc. (TLRY) reported strong fourth quarter financials and recorded a more than 20% increase in revenue when compared to the same period last year, broker-dealers have not responded as favorably as we anticipated. Following the earnings report, Tilray was downgraded by two broker-dealers and we found this to…

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has entered into an agreement with Cantor Fitzgerald Canada Corporation, as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (together, the “Underwriters”), pursuant to which the Underwriters have…

Last week, Aurora Cannabis Inc. (ACB.TO) (ACB) released second quarter financial results and the market responded negatively to the numbers. Following the earnings report, several leading Canadian and US broker-dealers responded with the following: ATB Capital Markets raised its price target to $13 from $10.50 (CAD) MKM Partners changed its…